Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Other Accumulated Expenses: 2024-2025

  • Core Scientific's Other Accumulated Expenses was N/A to $15.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year change of. This contributed to the annual value of $32.5 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Core Scientific's Other Accumulated Expenses stood at $15.7 million, which was down 7.24% from $16.9 million recorded in Q2 2025.
  • Core Scientific's 5-year Other Accumulated Expenses high stood at $32.5 million for Q4 2024, and its period low was $15.7 million during Q3 2025.
  • Moreover, its 2-year median value for Other Accumulated Expenses was $16.9 million (2025), whereas its average is $21.7 million.